Since GSK-3β inhibition can provide anti-inflammatory effects in vitro and in vivo, it could offset cytokine storm-related tissue injury during sepsis and might therefore act as an alternative therapeutic strategy beyond antibiotic treatment. The gene discussed is GSK3B; the disease is Sepsis.